Galstian G M, Kolosova I V
Anesteziol Reanimatol. 2014 Nov-Dec;59(6):60-6.
The review deals with an analysis of the use of recombinant activated factor clotting VII (rFVIIa) for the treatment of hemorrhagic syndrome in patients with thrombocytopenia. The review discusses cases of rFVIIa use during bleeding of different localization and different invasive interventions, a frequency of thrombotic complications and causes of the rFVlIIa insufficiency.
该综述分析了重组活化凝血因子VII（rFVIIa）用于治疗血小板减少症患者出血综合征的情况。综述讨论了rFVIIa在不同部位出血及不同侵入性干预过程中的使用病例、血栓形成并发症的发生率以及rFVIIa不足的原因。
